Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2015 3
2016 3
2017 3
2018 5
2019 3
2020 5
2021 5
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial.
Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, Peters C, Zhyzhneuskaya S, Al-Mrabeh A, Hollingsworth KG, Rodrigues AM, Rehackova L, Adamson AJ, Sniehotta FF, Mathers JC, Ross HM, McIlvenna Y, Stefanetti R, Trenell M, Welsh P, Kean S, Ford I, McConnachie A, Sattar N, Taylor R. Lean ME, et al. Among authors: al mrabeh a. Lancet. 2018 Feb 10;391(10120):541-551. doi: 10.1016/S0140-6736(17)33102-1. Epub 2017 Dec 5. Lancet. 2018. PMID: 29221645 Free article. Clinical Trial.
Understanding the mechanisms of reversal of type 2 diabetes.
Taylor R, Al-Mrabeh A, Sattar N. Taylor R, et al. Among authors: al mrabeh a. Lancet Diabetes Endocrinol. 2019 Sep;7(9):726-736. doi: 10.1016/S2213-8587(19)30076-2. Epub 2019 May 13. Lancet Diabetes Endocrinol. 2019. PMID: 31097391 Review.
Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial.
Lean MEJ, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, Peters C, Zhyzhneuskaya S, Al-Mrabeh A, Hollingsworth KG, Rodrigues AM, Rehackova L, Adamson AJ, Sniehotta FF, Mathers JC, Ross HM, McIlvenna Y, Welsh P, Kean S, Ford I, McConnachie A, Messow CM, Sattar N, Taylor R. Lean MEJ, et al. Among authors: al mrabeh a. Lancet Diabetes Endocrinol. 2019 May;7(5):344-355. doi: 10.1016/S2213-8587(19)30068-3. Epub 2019 Mar 6. Lancet Diabetes Endocrinol. 2019. PMID: 30852132 Clinical Trial.
Editorial: The role of GPCRs in obesity.
Zhang C, Wang Y, Kimura T, Al-Mrabeh AH. Zhang C, et al. Among authors: al mrabeh ah. Front Endocrinol (Lausanne). 2024 Apr 5;15:1404969. doi: 10.3389/fendo.2024.1404969. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38645430 Free PMC article. No abstract available.
Remission of Human Type 2 Diabetes Requires Decrease in Liver and Pancreas Fat Content but Is Dependent upon Capacity for β Cell Recovery.
Taylor R, Al-Mrabeh A, Zhyzhneuskaya S, Peters C, Barnes AC, Aribisala BS, Hollingsworth KG, Mathers JC, Sattar N, Lean MEJ. Taylor R, et al. Among authors: al mrabeh a. Cell Metab. 2018 Oct 2;28(4):547-556.e3. doi: 10.1016/j.cmet.2018.07.003. Epub 2018 Aug 2. Cell Metab. 2018. PMID: 30078554 Free article. Clinical Trial.
24 results